Zdrowie i gospodarka · 29/04/2024
FDA Releases Draft Guidance for Industry on Composition Statements in New Drug Applications and Abbreviated New Drug Applications
The FDA has released a draft guidance to help new drug application and abbreviated new drug application applicants accurately submit composition statements and corresponding ingredient statements in their applications and labels.